» Articles » PMID: 19419906

Prolonged RV Endocardial Activation Duration: a Novel Marker of Arrhythmogenic Right Ventricular Dysplasia/cardiomyopathy

Abstract

Background: Parietal block, defined as intra right ventricular (RV) conduction slowing, is a major diagnostic criterion for arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C).

Objective: We evaluated the utility of total RV endocardial activation duration (EAD) measured by 3-dimensional electroanatomic mapping during sinus rhythm in the diagnosis of ARVD/C.

Methods: Twenty-five consecutive patients with frequent left bundle branch block morphology premature ventricular complexes who underwent electroanatomic mapping as a part of the evaluation for ARVD/C were included in the study. All patients were evaluated using standard protocol that included electrocardiogram (ECG), signal-averaged ECG, Holter monitoring, echocardiography, and magnetic resonance imaging. Invasive testing was performed as indicated. Total RV EAD was measured as the time interval between the onset of RV activation to the latest activated region in the RV.

Results: The mean age of the study subjects was 38 +/- 11 years, and 32% were men. Fourteen subjects were diagnosed with ARVD/C using task force criteria, and the remainder had idiopathic ventricular tachycardia. Although the surface QRS durations were similar, the total RV EAD was significantly prolonged in ARVD/C compared with idiopathic VT (83.9 +/- 10 ms vs. 50.8 +/- 7 ms, P <.001). None of the idiopathic VT subjects had RV EAD of >65 ms. RV EAD also showed significant negative correlation with RV ejection fraction.

Conclusion: Total RV EAD obtained by 3-dimensional electroanatomic mapping is a sensitive marker of intra-RV conduction delay in ARVD/C, and a total RV EAD of >65 ms accurately differentiates ARVD/C from idiopathic VT.

Citing Articles

Epicardial conduction abnormalities in patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and mutation positive healthy family members - A study using electrocardiographic imaging.

Kommata V, Sciaraffia E, Blomstrom-Lundqvist C PLoS One. 2023; 18(1):e0280111.

PMID: 36603020 PMC: 9815642. DOI: 10.1371/journal.pone.0280111.


Prolonged Right Ventricular Outflow Tract Endocardial Activation Duration and Presence of Deceleration Zones in Patients With Idiopathic Premature Ventricular Contractions. Association With Low Voltage Areas.

Parreira L, Carmo P, Marinheiro R, Mesquita D, Farinha J, Esteves A Front Physiol. 2021; 12:699559.

PMID: 34276420 PMC: 8283314. DOI: 10.3389/fphys.2021.699559.


Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient.

Wang W, James C, Calkins H Europace. 2018; 21(1):9-21.

PMID: 29688316 PMC: 6321962. DOI: 10.1093/europace/euy063.


A novel noninvasive surface ECG analysis using interlead QRS dispersion in arrhythmogenic right ventricular cardiomyopathy.

Hsieh W, Lin C, Te A, Lo M, Wu C, Chung F PLoS One. 2017; 12(8):e0182364.

PMID: 28771538 PMC: 5542590. DOI: 10.1371/journal.pone.0182364.


New Imaging Technologies To Characterize Arrhythmic Substrate.

Dello Russo A, Conti S, Al-Mohani G, Casella M, Pizzamiglio F, Carbucicchio C J Atr Fibrillation. 2016; 7(4):1137.

PMID: 27957131 PMC: 5135199. DOI: 10.4022/jafib.1137.


References
1.
Tsatsopoulou A, Protonotarios N, McKenna W . Arrhythmogenic right ventricular dysplasia, a cell adhesion cardiomyopathy: insights into disease pathogenesis from preliminary genotype--phenotype assessment. Heart. 2006; 92(12):1720-3. PMC: 1861281. DOI: 10.1136/hrt.2005.081679. View

2.
Corrado D, Basso C, Thiene G, McKenna W, Davies M, Fontaliran F . Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997; 30(6):1512-20. DOI: 10.1016/s0735-1097(97)00332-x. View

3.
Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S . Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation. 2006; 114(17):1799-806. DOI: 10.1161/CIRCULATIONAHA.106.624502. View

4.
Dalal D, Nasir K, Bomma C, Prakasa K, Tandri H, Piccini J . Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation. 2005; 112(25):3823-32. DOI: 10.1161/CIRCULATIONAHA.105.542266. View

5.
Marchlinski F, Zado E, Dixit S, Gerstenfeld E, Callans D, Hsia H . Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation. 2004; 110(16):2293-8. DOI: 10.1161/01.CIR.0000145154.02436.90. View